# Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MDD

> **NCT03101540** · EARLY_PHASE1 · TERMINATED · sponsor: **William Coryell** · enrollment: 27 (actual)

## Conditions studied

- Major Depressive Disorder in Pregnancy

## Interventions

- **DRUG:** Omega-3 PUFA supplementation

## Key facts

- **NCT ID:** NCT03101540
- **Lead sponsor:** William Coryell
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-08
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 27 (ACTUAL)
- **Why stopped:** Insufficient recruitment
- **Last updated:** 2017-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03101540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03101540, "Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MDD". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03101540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*